Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells
- PMID: 15611282
- DOI: 10.4049/jimmunol.174.1.551
Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells
Abstract
NKT cells are a unique immunoregulatory T cell population that produces large amounts of cytokines. We have investigated whether stimulation of host NKT cells could modulate acute graft-vs-host disease (GVHD) in mice. Injection of the synthetic NKT cell ligand alpha-galactosylceramide (alpha-GalCer) to recipient mice on day 0 following allogeneic bone marrow transplantation promoted Th2 polarization of donor T cells and a dramatic reduction of serum TNF-alpha, a critical mediator of GVHD. A single injection of alpha-GalCer to recipient mice significantly reduced morbidity and mortality of GVHD. However, the same treatment was unable to confer protection against GVHD in NKT cell-deficient CD1d knockout (CD1d(-/-)) or IL-4(-/-) recipient mice or when STAT6(-/-) mice were used as donors, indicating the critical role of host NKT cells, host production of IL-4, and Th2 cytokine responses mediated by donor T cells on the protective effects of alpha-GalCer against GVHD. Thus, stimulation of host NKT cells through administration of NKT ligand can regulate acute GVHD by inducing Th2 polarization of donor T cells via STAT6-dependent mechanisms and might represent a novel strategy for prevention of acute GVHD.
Similar articles
-
Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.J Immunol. 2007 Nov 15;179(10):6579-87. doi: 10.4049/jimmunol.179.10.6579. J Immunol. 2007. PMID: 17982047
-
Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.Immunol Lett. 2006 Jul 15;106(1):82-90. doi: 10.1016/j.imlet.2006.05.001. Epub 2006 May 23. Immunol Lett. 2006. PMID: 16806496
-
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.J Clin Invest. 2000 May;105(9):1289-98. doi: 10.1172/JCI7894. J Clin Invest. 2000. PMID: 10792004 Free PMC article.
-
Regulation of immune responses by CD1d-restricted natural killer T cells.Immunol Res. 2004;30(2):139-53. doi: 10.1385/IR:30:2:139. Immunol Res. 2004. PMID: 15477656 Review.
-
Role of type II NKT cells in the suppression of graft-versus-host disease.Crit Rev Immunol. 2008;28(3):249-67. doi: 10.1615/critrevimmunol.v28.i3.50. Crit Rev Immunol. 2008. PMID: 19024348 Review.
Cited by
-
Current and future approaches for control of graft-versus-host disease.Expert Rev Hematol. 2008 Oct;1(1):111. doi: 10.1586/17474086.1.1.111. Expert Rev Hematol. 2008. PMID: 20151032 Free PMC article. Review.
-
Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Immunotherapy. 2009 Jul;1(4):599-621. doi: 10.2217/imt.09.32. Immunotherapy. 2009. PMID: 20191089 Free PMC article. Review.
-
Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses.J Immunol. 2010 Aug 15;185(4):2099-105. doi: 10.4049/jimmunol.0901985. Epub 2010 Jul 14. J Immunol. 2010. PMID: 20631307 Free PMC article.
-
Human invariant natural killer T cells: implications for immunotherapy.Int J Hematol. 2009 Sep;90(2):137-142. doi: 10.1007/s12185-009-0379-1. Epub 2009 Jul 29. Int J Hematol. 2009. PMID: 19639273 Review.
-
Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation.Nat Med. 2009 Apr;15(4):436-41. doi: 10.1038/nm.1948. Epub 2009 Mar 29. Nat Med. 2009. PMID: 19330008
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
